Lung Cancer Study Group
N E W S – F I L E
We thank all the congressmen, speakers, sponsors and partners who made the 1st Portuguese Lung Cancer Congress a real success! From Thursday to Saturday we were together for another scientific update and multidisciplinary debate on Lung Cancer. In this post-Congress…
The 1st Portuguese Lung Cancer Congress | 10th GECP has available a Mobile App with all the useful information of the event. To download the Mobile App use the following links: App in store Google Play or Apple Store. The…
We are counting down to the 10th Lung Cancer Study Group Congress / 1st Portuguese Lung Cancer Congress.In the words of Dr. Teresa Almodovar, president of GECP, this event “will last for three full days, with a space dedicated to…
The Journal of the Lung Cancer Study Group, Vol. XIX, nº2 of 2021, is now available for consultation and free download here! Access https://www.gecp.pt/revistas/ to consult this edition and other issues from previous years of Revista do GECP And if…
The 10th GECP Congress, which opens the Portuguese Lung Cancer Congress, will take place on the 20th, 21st and 22nd of October, in Troia, in an entirely face-to-face format. In this event, under the theme “Lugar ao Novo”, “we will…
“Don’t gamble with your life” is the alert from the Lung Cancer Study Group (GECP) on the occasion of the International Gamer Day, celebrated annually on August 29, with the aim of putting the topic of lung cancer on the…
Men Made Cancer: “Lung cancer is the biggest killer, but its main risk factors are modifiable” “Men Made Cancer” is the motto of the new campaign by the Lung Cancer Study Group (GECP) for World Lung Cancer Day, which is…
The drug Tecentriq (atezolizumab) obtained authorization from the National Authority for Medicines and Health Products (Infarmed) to be used in hospitals in new indications for the treatment of lung cancer. According to the grant recently published on the Infarmed website,…
Dr. Fernanda EstevinhoOncologist at Hospital Pedro Hispano – ULS MatosinhosSelected Article: “Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data” O artigo selecionado…
To celebrate this anniversary, we recall the GECP’s journey through the most used digital communication networks around the world.After our debut on Facebook and Instagram in May 2020, we created an institutional page on LinkedIn last year.At a time when…
Lung cancer is more than smoking” is the motto of the GECP campaign to mark the World No Tobacco Day, which is celebrated annually on the 31st of May.Today we focus on demystifying the stigma associated with lung cancer, warning…
GECP has just launched another digital initiative that aims to promote regular scientific updating and the sharing of ideas among peers. It is entitled “Selected Article” and gives voice to the members of the Scientific Committee of the GECP, inviting…
